AAAAAA

   
Results: 1-8 |
Results: 8

Authors: BECK JF BUCHHOLZ F ULRICH WR BOER R SANDERS KH NIETHAMMER D GEKELER V
Citation: Jf. Beck et al., RHODAMINE-123 EFFLUX MODULATION IN THE PRESENCE OF LOW OR HIGH SERUM FROM CD56(-CELLS OR CD34(+) LEUKEMIC BLASTS BY B9309-068, A NEWLY DESIGNED PYRIDINE DERIVATIVE() HEMATOPOIETIC), Cancer letters, 129(2), 1998, pp. 157-163

Authors: ISE W BAUR I HEUSER M LOFFLER S STEINHILBER W ULRICH WR WIESBACHER M
Citation: W. Ise et al., NEW METHOD FOR THE QUANTIFICATION OF HOST-CELL PROTEIN IN RECOMBINANTLUNG SURFACTANT PROTEIN SP-C, The FASEB journal, 11(9), 1997, pp. 613-613

Authors: BOER R GEKELER V ULRICH WR ZIMMERMANN P ISE W SCHODL A HAAS S
Citation: R. Boer et al., MODULATION OF P-GLYCOPROTEIN MEDIATED DRUG ACCUMULATION IN MULTIDRUG-RESISTANT CCRF VCR-1000 CELLS BY CHEMOSENSITIZERS, European journal of cancer, 32A(5), 1996, pp. 857-861

Authors: ELTZE M BOER R SANDERS KH PRUSSE W ULRICH WR
Citation: M. Eltze et al., B8805-033 - AN EXTREMELY ALPHA(1A)-ADRENOCEPTOR-SELECTIVE ANTAGONIST, Naunyn-Schmiedeberg's archives of pharmacology, 354(4), 1996, pp. 35-35

Authors: BOER R ULRICH WR HAAS S BORCHERS C GEKELER V BOSS H PRZYBYLSKI M SCHODL A
Citation: R. Boer et al., INTERACTION OF CYTOSTATICS AND CHEMOSENSITIZERS WITH THE DEXNIGULDIPINE BINDING-SITE ON P-GLYCOPROTEIN, European journal of pharmacology, 295(2-3), 1996, pp. 253-260

Authors: BOER R DICHTL M BORCHERS C ULRICH WR MARECEK JF PRESTWICH GD GLOSSMANN H STRIESSNIG J
Citation: R. Boer et al., REVERSIBLE LABELING OF A CHEMOSENSITIZER BINDING DOMAIN OF P-GLYCOPROTEIN WITH A NOVEL 1,4-DIHYDROPYRIDINE DRUG TRANSPORT INHIBITOR, Biochemistry, 35(5), 1996, pp. 1387-1396

Authors: BORCHERS C ULRICH WR KLEMM K ISE W GEKELER V HAAS S SCHODL A CONRAD J PRZYBYLSKI M BOER R
Citation: C. Borchers et al., B9209-005, AN AZIDO DERIVATIVE OF THE CHEMOSENSITIZER DEXNIGULDIPINE-HCL, PHOTOLABELS P-GLYCOPROTEIN, Molecular pharmacology, 48(1), 1995, pp. 21-29

Authors: GEKELER V ISE W SANDERS KH ULRICH WR BECK J
Citation: V. Gekeler et al., THE LEUKOTRIENE LTD(4) RECEPTOR ANTAGONIST MK571 SPECIFICALLY MODULATES MRP ASSOCIATED MULTIDRUG-RESISTANCE, Biochemical and biophysical research communications, 208(1), 1995, pp. 345-352
Risultati: 1-8 |